Oxybutynin and Intranasal Desmopressin for Clozapine-Induced Urinary Incontinence
J Clin Psychiatry 1997;58:404 [letters]
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Letter to the Editor
Sir: In their report on the efficacy of ephedrine in the treatment
of clozapine-induced urinary incontinence, Fuller et al.
report that in their clinical experience with hospitalized psychiatric
patients oxybutynin was ineffective in the management of
this side effect. We have found both oxybutynin and intranasal
desmopressin to be effective in the treatment of outpatients with
clozapine-induced urinary incontinence.
As part of the Continuing Care Division, a community-based
program of services for the severely and persistently mentally
ill, the Clozapine Treatment Program provides case management
and medical services to 71 patients with treatmentresistant
psychosis managed with clozapine.